eISSN: 2450-4459
ISSN: 2450-3517
Lekarz POZ
Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors
Editorial System
Submit your Manuscript
Search
5/2017
vol. 3
 
Share:
Send email
Share:
abstract:
Review paper

Etoricoxib – the possibility of its use in the practice of the general practitioner

Agnieszka Mastalerz-Migas
,
Brygida Kwiatkowska
,
Maria Majdan
,
Maciej Niewada
,
Barbara Skrzydło-Radomańska
,
Artur Mamcarz

Online publish date: 2017/11/29
View full text Get citation
 
Pain is an inherent element of rheumatoid diseases and significantly worsens the quality of life of the patients. Therefore, patients with pain conditions in osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis or gout should receive efficient pain management. Selection of an effective and safe drug for the patient is a great challenge for the general practitioner. Difficulties in selecting the best drug apply mainly to patients with comorbidities, especially the elderly because in that group of patients the risk of drug interactions and potential complications is significantly greater. For patients with a high risk of gastroenterological complications or in the case of concerns about hepatotoxicity of nonsteroidal anti-inflammatory drug (NSAID) therapy, with a low cardiovascular risk, coxibs, including Etoricoxib should be the first-choice drugs.
keywords:

Etoricoxib, coxibs, cyclooxygenase COX-2, pain management, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, gout
FEATURED PRODUCTS
BOOKS
• Choroby alergiczne w praktyce lekarza rodzinnego • Medycyna rodzinna.
Podręcznik dla lekarzy i studentów
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.